Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen [NA]
Clinical trial status update on a study evaluating transcranial alternating current stimulation with pre-cognitive behavioral therapy for ps…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: BXCL501 for Agitation in Schizophrenia [Phase 1]
Phase 1 study of BXCL501 for agitation in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Exercise and Olanzapine-samidorphan [Phase 4]
A Phase 4 clinical trial is evaluating exercise in combination with olanzapine-samidorphan for schizophrenia and related disorders, includin…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? [Phase 4]
Phase 4 clinical trial investigated whether adding divalproex sodium ER to an atypical antipsychotic improves cognition and psychopathology …
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating MMFS-202-302 for cognitive enhancement in schizophrenia and schizoaffective disorder has completed. Result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-13FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic Clozapine product from Mylan Pharmaceuticals (ANDA201824). This action expands acc…
-
FDA approval · 2025-06-13FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application from Mylan Pharmaceuticals Inc. to market a generic clozapine product (Clozapine) through an ANDA.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Peripheral Immune System in Individuals With Schizophrenia
This entry reports the completion of a Stanford University clinical trial studying the peripheral immune system in individuals with schizoph…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders
This clinical trial update reports the completion of a survey examining reproductive and child-rearing situations among adults with severe m…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia [Phase 2]
A Phase 2 trial evaluating focused ultrasound modulation of the globus pallidus interna for schizophrenia has completed, and results have be…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder [Phase 4]
Phase 4 controlled trial results for brexpiprazole in patients with schizophrenia and co-occurring substance use disorder; results have been…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: iTBS to Enhance Social Cognition in People With Psychosis [NA]
A clinical trial is testing whether intermittent theta-burst stimulation (iTBS) can improve social cognition in people with psychosis, inclu…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination [NA]
This clinical trial entry describes an ongoing study evaluating whether transcranial direct current stimulation (tDCS)–mediated neuroplastic…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating metabolic effects of adjunctive lumateperone in clozapine-treated patients with schizophrenia is currently…
-
CLINICAL_TRIALS other · 2025-04-27Clinical Trial Update: Sustainable Early Episode Clinic Study (SEEC) [NA]
Janssen-sponsored clinical trial SEEC for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Open Label Extension Study of NCT06221852 [NA]
Open-label extension study NCT06221852 is currently enrolling by invitation. The sponsor is McLean Hospital and the study targets Bipolar I …
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders [Phase 2]
Phase 2 clinical trial evaluating the effects of intranasal insulin on neuroimaging markers and cognition in patients with psychotic disorde…
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 trial evaluating the safety and tolerability of Lyndra's long-acting oral risperidone (LYN-005) in schizophrenia or schizoaffectiv…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: 40 Hz Visual Stimulation as an Intervention in Schizophrenia [NA]
A clinical trial from Technical University of Munich is evaluating 40 Hz visual stimulation as an intervention for negative symptoms in schi…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia [NA]
This clinical trial update describes ongoing research evaluating non-invasive brain stimulation to improve treatment adherence in schizophre…
-
FDA approval · 2025-03-27FDA Approved: PALIPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for paliperidone by Ajanta Pharma USA Inc., supporting a generic version of the drug. This action re…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors [NA]
A completed clinical trial update from Northwestern University examining genetic risk factors in schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]
A Phase 4 clinical trial assessing gamma-aminobutyric acid (GABA) function in psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training [NA]
This completed Vanderbilt University trial compares virtual reality training for social skills in schizophrenia to cognitive training, with …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Neural Biomarkers of Clozapine Response
A completed clinical trial from the University of Pittsburgh examining neural biomarkers associated with clozapine response in schizophrenia…